Antisense oligonucleotides in therapy for neurodegenerative disorders

Author(s):
Evers, M.M.; Toonen, L.J.A.; Roon-Mom, W.M.C. van
Published
2015
Publication type
Article / Letter to editor
Genetic therapiesNeurodegenerative disordersBlood brain barrierSplicing modulationRNase H-mediated degradationAllele-specific reductionTranslational blockage
Date issued
2015-06-29
Language
English
Is part of
Advanced Drug Delivery Reviews (2015), Vol. 87, p. 90-103
hdl
1887/105400
doi
10.1016/jaddr.2015.03.008